🔎 Trials Near Me

Home › Non-Hodgkin Lymphoma › Pennsylvania › Philadelphia

Non-Hodgkin Lymphoma clinical trials in Philadelphia, PA

20 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
  • Children's Hospital of Philadelphia, Philadelphia
Ages 0 to 38 · All sexes · Updated Oct 1, 2026 · NCT06131801

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RecruitingPhase 2
  • Fox Chase Cancer Center, Philadelphia
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • University of Pennsylvania Abramson Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

RecruitingPhase 1/2
  • Research Site, Philadelphia
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
  • Research Site, Philadelphia
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

RecruitingPhase 1
  • Hospital of the University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07082803

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • Thomas Jefferson University, Philadelphia
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
  • University of Pennsylvania / Abramson Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

RecruitingPhase 1
  • Abramson Cancer Center, University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT07478848

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

RecruitingPhase 1/2
  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT04068597

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

RecruitingPhase 2
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT06458439

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
1 Month – 25 Years · All sexes · Updated Apr 15, 2026 · NCT06839456

SynKIR-310 for Relapsed/Refractory B-NHL

RecruitingPhase 1
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

RecruitingPhase 4
  • University of Pennsylvania Hospital, Philadelphia
Ages 18 and older · All sexes · Updated Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

RecruitingPhase 4
  • University of Pennsylvania Hospital, Philadelphia
Ages 18 and older · All sexes · Updated Mar 2, 2026 · NCT06876662

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

RecruitingPhase 2
  • Thomas Jefferson University Hospital, Philadelphia
Ages 18 and older · All sexes · Updated Nov 28, 2025 · NCT07188090

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Philadelphia
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Non-Hodgkin Lymphoma trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.